Publications

Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): Case reports from the SENTRY Antimicrobial Surveillance Program. by Kugler KC, Denys GA, Wilson ML, and Jones RN published in Diagn. Microbiol. Infect. Dis. 2000; 36 (4): 269-272

In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997- 1998. by Jones RN, Jenkins SG, Hoban DJ, Pfaller MA and Ramphal R published in Int. J. Antimicrob. Agents. 2000; 15 (2): 111-118

In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. by Jones RN, Jenkins SG, Hoban DJ, Pfaller MA and Ramphal R published in Diagn. Microbiol. Infect. Dis. 2000; 37 (2): 93-98

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). by Jones RN, Croco MA, Kugler KC, Pfaller MA and Beach ML published in Diagn. Microbiol. Infect. Dis. 2000; 37 (2): 115-125

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: Data from the SENTRY Antimicrobial Surveillance Program. by Jones RN and Pfaller MA. published in Clin. Infect. Dis. 2000; 31 (Suppl 2): S16-23

Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: Significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999). by Jones RN and Pfaller MA published in J. Clin. Microbiol. 2000; 38 (11): 4298-4299

Potencies of newer fluoroquinolones against viridans group streptococci isolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada! by Jones RN and Pfaller MA published in Antimicrob. Agents Chemother. 2000; 44 (10): 2922-2923

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). by Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, Pfaller MA and Doern GV published in J. Antimicrob. Chemother. 2000; 45 (3): 295-303

Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 1997-98. SENTRY Study Group. by Gales AC, Jones RN, Pfaller MA, Gordon KA and Sader HS published in Int. J. Infect. Dis. 2000; 4 (2): 75-84

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. by Diekema DJ, Pfaller MA, Jones RN, Doern GV, Kugler KC, Beach ML and Sader HS published in Int. J. Antimicrob. Agents 2000; 13 (4): 257-271

Genetic relatedness of multidrug-resistant, methicillin (oxacillin)- resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance centers worldwide, 1998. by Diekema DJ, Pfaller MA, Turnidge J, Verhoef J, Bell J, Fluit AC, Doern GV and Jones RN published in Microb. Drug Resist. 2000; 6 (3): 213-221

Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: Results from SENTRY Antimicrobial Surveillance Program (1997-98). by Sader HS, Gales AC, Granacher TD, Pfaller MA and Jones RN published in Braz. J. Infect. Dis. 2000; 4 (5): 245-254

Fluoroquinolone-resistant Haemophilus influenzae: Frequency of occurrence and analysis of confirmed strains in the SENTRY Antimicrobial Surveillance Program (North and Latin America). by Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2000; 36 (4): 255-259

Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. by Ramphal R, Hoban DJ, Pfaller MA, Jones RN. published in Diagn. Microbiol. Infect. Dis. 2000; 36 (2): 125-129

Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the western hemisphere. by Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN and Doern GV published in Am. J. Obstet. Gynecol. 2000; 183 (4): 859-862

Bacterial pathogens isolated from patients with bloodstream infections in Latin America, 1997: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program. by Sader HS, Pfaller MA, Jones RN, Doern GV, Gales AC, Winokur PL and Kugler KC published in Braz. J. Infect. Dis. 1999; 3 (3): 97-110

Results of the 1997 SENTRY Antimicrobial Surveillance Program in three Brazilian medical centers. by Sader HS, Sampaio JL, Zoccoli C and Jones RN published in Braz. J. Infect. Dis. 1999; 3 (2): 63-79

Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. by Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, and Beach ML published in Diagn. Microbiol. Infect. Dis. 1999; 33 (4): 283-297

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). by Pfaller MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, Messer SA, Houston A, Coffman S and Hollis RJ published in Diagn. Microbiol. Infect. Dis. 1999; 35 (1): 19-25

Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe). by Odland BA, Jones RN, Verhoef J, Fluit A and Beach ML published in Diagn. Microbiol. Infect. Dis. 1999; 34 (4):315-320

Characteristics of pathogens causing urinary tract infections in hospitals in North America: Results from the SENTRY Antimicrobial Surveillance Program, 1997. by Jones RN, Kugler KC, Pfaller MA and Winokur PL published in Diagn. Microbiol. Infect. Dis. 1999; 35 (1): 55-63

Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: Results from the SENTRY Antimicrobial Surveillance Program (1997). by Jones RN, Winokur PL, Pfaller MA, Doern GV and Barrett T published in Clin. Microbiol. Infect. 1999; 5 (8): 478-487

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). by Doern GV, Jones RN, Pfaller MA and Kugler K published in Antimicrob. Agents Chemother. 1999; 43 (2): 385-389

Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). by Doern GV, Jones RN, Pfaller MA, Kugler KC and Beach ML published in Diagn. Microbiol. Infect. Dis. 1999; 34 (1): 65-72

In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. by Diekema DJ, Pfaller MA, Messer SA, Houston A, Hollis RJ, Doern GV and Jones RN published in Antimicrob. Agents Chemother. 1999; 43 (9): 2236-2239

Survey of bloodstream infections due to Gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. by Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, and Beach M published in Clin. Infect. Dis. 1999; 29 (3): 595-607

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada – 1997 results from the SENTRY Antimicrobial Surveillance Program. by Doern GV, Pfaller MA, Erwin ME, Brueggemann AB and Jones RN published in Diagn. Microbiol. Infect. Dis. 1998; 32 (4): 313-316

Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: Report from the SENTRY Antimicrobial Surveillance Program (1998). by DiPersio JR, Jones RN, Barrett T, Doern GV and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 1998; 32 (2): 131-135

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. by Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1998; 32 (4): 289-301

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. by Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ and Messer SA published in J. Clin. Microbiol. 1998; 36 (7): 1886-1889

Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). by Pfaller MA, Jones RN, Doern GV and Kugler K published in Antimicrob. Agents. Chemother. 1998; 42 (7): 1762-1770

Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. SENTRY Antimicrobial Surveillance Program. by Jones ME, Jones RN, Sader H, Verhoef J and Acar J published in J. Antimicrob. Chemother. 1998; 42 (1): 119-121

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. by Doern GV, Pfaller MA, Kugler K, Freeman J and Jones RN published in Clin. Infect. Dis. 1998; 27 (4): 764-770